Senseonics Holdings, Inc. (SENS) |
|
0.7601 -0.086 (-10.16%)
|
03-22 13:09 |
|
Open: |
0.8425 |
Pre. Close: |
0.8461 |
|
High:
|
0.8492 |
Low:
|
0.76 |
|
Volume:
|
4,783,778 |
Market Cap:
|
365(M) |
|
|
|
Technical analysis |
as of: 2023-03-22 12:50:01 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 1.15 One year: 1.31 |
| Support: |
Support1: 0.76 Support2: 0.63 |
| Resistance: |
Resistance1: 0.98 Resistance2: 1.12 |
| Pivot: |
0.91 |
| Moving Average: |
MA(5): 0.82 MA(20): 0.93
MA(100): 1.08 MA(250): 1.27 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 11 %D(3): 10 |
| RSI: |
RSI(14): 30.3 |
| 52-week: |
High: 2.44 Low: 0.76 |
| Average Vol(K): |
3-Month: 2,723 (K) 10-Days: 4,811 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SENS ] has closed above bottom band by 1.9%. Bollinger Bands are 60.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.86 - 0.86 |
0.86 - 0.87 |
|
Low:
|
0.81 - 0.81 |
0.81 - 0.81 |
|
Close:
|
0.84 - 0.85 |
0.85 - 0.85 |
|
Company Description |
|
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. |
Headline News |
Tue, 21 Mar 2023
PHC Holdings Now Owns 15.41% of Senseonics - 24/7 Wall St.
Mon, 20 Mar 2023
DexCom Inc. stock rises Monday, outperforms market - MarketWatch
Mon, 20 Mar 2023
The Continuous Glucose Monitoring (CGM) Sensors Market ... - Digital Journal
Fri, 17 Mar 2023
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
Wed, 15 Mar 2023
Senseonics Holdings Inc earnings beat by $0.06, revenue topped ... - Investing.com
Wed, 15 Mar 2023
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year ... - Business Wire
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
446 (M) |
| Shares Float |
316 (M) |
|
% Held by Insiders
|
10.1 (%) |
|
% Held by Institutions
|
31.3 (%) |
|
Shares Short
|
75,530 (K) |
|
Shares Short P.Month
|
76,920 (K) |
Stock Financials |
|
EPS
|
-1.31 |
|
EPS Est Next Qtl
|
-0.16 |
|
EPS Est This Year
|
-0.55 |
|
EPS Est Next Year
|
-0.64 |
|
Book Value (p.s.)
|
-0.61 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-395.1 |
|
Return on Assets (ttm)
|
-25.4 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
360.5 |
|
Gross Profit (p.s.)
|
-0.04 |
|
Sales Per Share
|
0.03 |
|
EBITDA (p.s.)
|
-0.12 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-53 (M) |
|
Levered Free Cash Flow
|
-35 (M) |
Stock Valuations |
|
PE Ratio
|
-0.59 |
|
PEG Ratio
|
-0.2 |
|
Price to Book value
|
-1.28 |
|
Price to Sales
|
25.26 |
|
Price to Cash Flow
|
-6.52 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
